# FDA Inspection 1049586 - Biomat USA Inc - February 15, 2018

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/b0ceccde-64eb-4a1d-b4ed-64236f584c29
Source feed: FDA_Inspections

> FDA Inspection 1049586 for Biomat USA Inc on February 15, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1049586
- Company Name: Biomat USA Inc
- Inspection Date: 2018-02-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 985568 - 2016-05-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/2afea6cf-aa0e-4510-84af-f407989bb00d)
- [FDA Inspection 896180 - 2014-09-17](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/ac8bbbe0-cdc4-45ca-adca-f0fe6adfbaf2)
- [FDA Inspection 746815 - 2011-09-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/e16e29e3-1ccb-4b62-a639-68d55150a762)
- [FDA Inspection 576969 - 2009-04-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/d0326678-bffe-46c6-91f4-bd4b51f9c5e7)

Company: https://www.keypedia.com/companies/biomat-usa-inc/8d621cff-bb83-4bf9-8740-84c1c10acad6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d